The company has received clearance from the US FDA to start an open-label Phase I trial for RespiRx nicotine inhaler in ...

SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess casdatifan plus volrustomig for renal ...

The BHF claims women are less likely than men to seek medical attention when experiencing a cardiac episode.

On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy ...

Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.

Johnson & Johnson has reported Phase III data where CARVYKTI improved overall survival in patients with multiple myeloma.

The retrospective study presented at ESMO 2024 involved about 2,400 patients with stage 3 or 4 non-small cell lung cancer.

Moderna has dosed the first subject in the US in its Phase III Nova 301 clinical trial of its investigational norovirus vaccine, mRNA-1403.

The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.

The Phase III TEMPO-1 trial enrolled 529 adults, between the ages of 40 and 80, diagnosed with Parkinson’s for less than three years.

The trial aims to enrol 87 subjects with low-grade intermediate-risk non-muscle invasive bladder cancer. Credit: Antonio Marca/Shutterstock. UroGen Pharma has announced the dosing of the first subject ...